カリフォルニア州サンタクララ - 現在1株$2.12で取引されている時価総額5,650万ドルの医療技術のパイオニアHeartBeam, Inc. (NASDAQ: BEAT)は、革新的な12誘導心電図(ECG)合成ソフトウェアの510(k)申請を米国食品医薬品局(FDA)に提出したと発表しました。この ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today ...

HeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k ...

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has submitted a 510(k) application ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

Overview: HeartBeam, Inc. is a medical technology company that develops and commercializes ambulatory electrocardiogram solutions for cardiac disease detection and monitoring in various settings, with ...